Mammary duct ectasia (MDE) is a non-bacterial inflammatory disease based on mammary duct dilation, accompanied by the accumulation of plasma cells around the mammary duct. It has a long course of disease, complicated lesions, and is more common in women of childbearing age who are not breastfeeding. At present, the pathogenesis of this disease are still unclear, and the treatment is difficult and prone to recurrence. If not treated in time, it may develop into fistula, which will aggravate the condition and affect the prognosis of patients. This article aims to provide an overview of the diagnosis, four stages of treatment and complications of MDE in recent years, to provide a reference for clinical selection of appropriate treatment options.
HomeArticlesVol 35,2025 No.2Detail
Research progress on the treatment of mammary duct ectasia at different stages
Published on Feb. 25, 2025Total Views: 8318 timesTotal Downloads: 1722 timesDownloadMobile
- Abstract
- Full-text
- References
Abstract
Full-text
References
1.Cutler M. Plasma-cell mastitis; report of a case with bilateral involvement[J]. Br Med J, 1949, 1(4593): 94-96. DOI: 10.1136/bmj.1.4593.94.
2.娄永庆,陈红跃,蒋俊玲. 浆细胞性乳腺炎的研究进展[J]. 智慧健康, 2021, 7(8): 31-35. [Lou YQ, Chen HY, Jiang JL. Research progress of plasma cell mastitis[J]. Smart Healthcare, 2021, 7(8): 31-35.] DOI: 10.19335/j.cnki.2096-1219.2021.08.010.
3.Zheng Y, Wang L, Han X, et al. Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis[J]. Exp Biol Med (Maywood), 2022, 247(2): 97-105. DOI: 10.1177/15353702211049361.
4.李孟晗,许斌,秦熙谣,等. 许斌治疗浆细胞性乳腺炎肿块期经验概要[J]. 实用中医内科杂志, 2024, 38(2): 28-30. [Li MH, Xu B, Qin XY, et al. Summary of XU Bin's experience in treatment plasma cell mastitis masses[J]. Journal of Practical Traditional Chinese Internal Medicine, 2024, 38(2): 28-30.] DOI: 10.13729/j.issn.1671-7813.Z20230096.
5.Xu Y, Da B, Zhao F, et al. Corrective surgery for nipple depression in patients with plasmacytic mastitis-a single-center experience[J]. Front Med (Lausanne), 2023, 10: 1156628. DOI: 10.3389/fmed.2023.1156628.
6.Ming J, Meng G, Yuan Q, et al. Clinical characteristics and surgical modality of plasma cell mastitis: analysis of 91 cases[J]. Am Surg, 2013, 79(1): 54-60. https://pubmed.ncbi.nlm.nih.gov/23317612/
7.Chen R, Hu B, Zhang Y, et al. Differential diagnosis of plasma cell mastitis and invasive ductal carcinoma using multiparametric MRI[J]. Gland Surg, 2020, 9(2): 278-290. DOI: 10.21037/gs.2020. 03.30.
8.Hu J, Huang X. Combining ultrasonography and mammography to improve diagnostic accuracy of plasma cell mastitis[J]. J Xray Sci Technol, 2020, 28(3): 555-561. DOI: 10.3233/XST-190607.
9.Xing M, Zhang S, Zha X, et al. Current understanding and management of plasma cell mastitis: can we benefit from what we know?[J]. Breast Care (Basel), 2022, 17(3): 321-329. DOI: 10.1159/000517572.
10.何瑞红,李立,钱伟军. DCE-MRI、多b值DWI结合CA153、CEA对乳腺癌及肿块型浆细胞性乳腺炎的鉴别诊断价值研究[J]. 中国CT和MRI杂志, 2023, 21(6): 89-92. [He RH, Li L, Qian WJ. The differential diagnosis value of DCE-MRI, Multi-b value DWI combined with CA153 and CEA in breast cancer and lumpy plasma cell mastitis[J]. Chinese Journal of CT and MRI, 2023, 21(6): 89-92.] DOI: 10.3969/j.issn.1672-5131. 2023.06.030.
11.尹成方,章阳,柳玉新,等. 乳腺导管扩张症的CT诊断(附3例报告)[J]. 医学影像学杂志, 2001, 11(1): 29. [Yin CF, Zhang Y, Liu YX, et al. CT diagnosis of ductal breast asis (3 reports) [J]. Journal of Medical Imaging, 2001, 11(1): 29.] DOI: 10.3969/j.issn.1006-9011.2001.01.036.
12.王煜. 超声、CT、MRI在不同类型浆细胞性乳腺炎中的诊断效果对比研究[J]. 黑龙江医学, 2022, 46(3): 309-312. [Wang Y. Comparative study on the diagnostic effect of Ultrasound, CT and MRI in different types of serous mastitis[J]. Heilong Medical Jouranl, 2022, 46(3): 309-312.] DOI: 10.3969/j.issn.1004-5775. 2022.03.019.
13.陈玲,陈晔,林建坤,等. 钼靶、多模态MRI对乳腺癌及肿块型浆细胞性乳腺炎的鉴别诊断价值研究[J]. 现代生物医学进展, 2022, 22(7): 1272-1276, 1314. [Chen L, Chen Y, Lin JK, et al. Differential diagnosis of breast cancer and mass plasma cell mastitis by molybdenum target and multimodal MRI[J]. Progress in Modern Biomedicine, 2022, 22(7): 1272-1276, 1314.] DOI: 10.13241/j.cnki.pmb.2022.07.016.
14.许锐,郭倩倩,杨乐平,等. 非哺乳期乳腺炎患者血液中自身抗体和免疫指标的变化及其临床意义[J]. 南方医科大学学报, 2016, 36(8): 1157-1159, 1168. [Xu R, Guo QQ, Yang LP, et al. Variations of peripheral blood autoantibody, immunoglobuliln, and complement levels in patients with non-lactational mastitis and their clinical significances[J]. Journal of Southern Medical University, 2016, 36(8): 1157-1159, 1168.] DOI: 10.3969/j.issn. 1673-4254.2016.08.24.
15.Liu L, Xiong H, Wang X, et al. Gold nanomaterials: important vectors in biosensing of breast cancer biomarkers[J]. Anal Bioanal Chem, 2024, 416(17): 3869-3885. DOI: 10.1007/s00216-024-05151-w.
16.Hamwi MW, Winters R. Mammary Duct Ectasia[M]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025. https://pubmed.ncbi.nlm.nih.gov/32491597/
17.彭金娟,张云锁,杨卉,等. 纤维乳管镜冲洗联合O3治疗溢液肿块期浆细胞性乳腺炎[J]. 中华乳腺病杂志(电子版), 2019, 13(4): 202-206. [Peng JJ, Zhang YS, Yang H, et al. Fiberoptic ductoscopy and O3 treatment for plasma cell mastitis with nipple discharge and lumps[J]. Chinese Journal of Breast Disease (Electronic Edition), 2019, 13(4): 202-206.] DOI: 10.3877/cma.j.issn.1674-0807.2019.04.003.
18.Zhou F, Shang XC, Tian XS, et al. Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese society of breast surgery (CSBrS) practice guideline 2021[J]. Chin Med J (Engl), 2021, 134(15): 1765-1767. DOI: 10.1097/CM9.0000000000001532.
19.董军. 手术区段切除联合糖皮质激素治疗浆细胞性乳腺炎的疗效分析[J]. 中国性科学, 2020, 29(10): 114-116. [Dong J. Therapeutic effect of surgical segmental excision combined with glucocorticoid in the treatment of plasma cell mastitis[J]. Chinese Journal of Human Sexuality, 2020, 29(10): 114-116.] DOI: 10.3969/j.issn.1672-1993.2020.10.031.
20.卢文亮,王敏. 四步探查法手术治疗顽固复发性浆细胞性乳腺炎128例报告[J]. 中国现代手术学杂志, 2022, 26(6): 429-433. [Lu WL, Wang M. Four-step surgical exploration for intractable recurrent plasma cell mastitis:128 cases report[J]. Chinese Journal of Modern Operative Surgery, 2022, 26(6): 429-433.] DOI: 10.16260/j.cnki.1009-2188.2022.06.004.
21.韦猛. 48例浆细胞性乳腺炎患者的诊断与治疗方法回顾 [J]. 检验医学与临床, 2020, 17(5): 682-685. [Wei M. Review of diagnosis and treatment methods in 48 patients with plasmacytic mastitis[J]. Laboratory Medicine and Clinic, 2020, 17(5): 682-685.] DOI: 10.3969/j.issn.1672-9455.2020.05.035.
22.陈一恒,姚昶,邱榕. 清挂线创疗法治疗肿块期浆细胞性乳腺炎42例临床研究[J]. 江苏中医药, 2024, 56(1): 44-47. [Chen YH, Yao C, Qiu R. Clinical study of 42 cases of mass stage plasma cell mastitis[J]. Jiangsu Journal of Traditional Chinese Medicine, 2024, 56(1): 44-47.] DOI: 10.19844/j.cnki.1672-397X.2024.01.012.
23.耿小峰,齐华美. 微创旋切术治疗乳腺导管扩张症的临床效果[J]. 妇儿健康导刊, 2024, 3(8):102-105. [Geng XF, Qi HM. Clinical effect of minimally invasive surgery in the treatment of mammary duct ectasia[J]. Journal of Women and Children's Health Guide, 2024, 3(8):102-105.] https://www.cnki.com.cn/Article/CJFDTotal-FEJK202408013.htm
24.徐玲,潘华锋. 微创旋切术、开放手术、穿刺抽液术治疗脓肿期浆细胞性乳腺炎的疗效分析[J]. 临床外科杂志, 2023, 31(3): 223-226. [Xu L, Pan HF. Comparative study on the curative effect of minimally invasive mammotome biopsy, open surgery and aspiration for plasma cell mastitis in abscess stage[J]. Journal of Clinical Surgery, 2023, 31(3): 223-226.] DOI: 10.3969/j.issn.1005-6483.2023.03.007.
25.Tong Y, Hao Y, Gao X, et al. Dexamethasone combined metronidazole on mammary duct ectasia and its relationship with serum IL-10 and IL-17[J]. J Obstet Gynaecol Res, 2020, 46(10): 2134-2141. DOI: 10.1111/jog.14380.
26.Ji LY, Xu DL, Yin SP, et al. First report in China on the identification and drug sensitivity of mycobacterium elephantis isolated from the milk of a cow with mastitis[J]. Biomed Environ Sci, 2017, 30(7): 501-507. DOI: 10.3967/bes2017.066.
27.Wood JR. Mammary duct ectasia: symptomatology, diagnosis, and treatment[J]. Radiol Technol, 2021, 92(4): 383M-398M. https://pubmed.ncbi.nlm.nih.gov/33653931/
28.Zhou F, Li H, Wang F, et al. Efficacy and safety of rifampicin-based triple therapy for non-puerperal mastitis: a single-arm, open-label, prospective clinical trial[J]. Int J Infect Dis, 2024, 140: 25-30. DOI: 10.1016/j.ijid.2023.12.008.
29.陈金桃,刘杰,李素贞,等.三联抗菌与激素抗炎治疗浆细胞性乳腺炎的效果比较[J]. 中国实用医药, 2020, 15(19): 62-64. [Chen JT, Liu J, Li SZ, et al. Comparison of the effect of triple antibacterial and hormone anti-inflammatory treatment in plasmacytic mastitis[J]. China Practical Medical, 2020, 15(19): 62-64.] DOI: 10.14163/j.cnki.11-5547/r.2020.19.025.
30.Liu C, Yu H, Chen G, et al. An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: a nonrandomized controlled trial[J]. Elife, 2023, 12: e84414. DOI: 10.7554/eLife.84414.
31.Xu H, Liu R, Lv Y, et al. Treatments for periductal mastitis: systematic review and Meta-analysis[J]. Breast Care (Basel), 2022, 17(1): 55-62. DOI: 10.1159/000514419.
32.Xu H, Jiang Y, Liao M, et al. Continuous postoperative negative pressure irrigation assisted mammaplasty in treating chronic refractory plasma cell mastitis[J]. Gland Surg, 2020, 9(6): 2071-2078. DOI: 10.21037/gs-20-795.
33.Zhou Y, Xu ZF, Xing W, et al. Comparative study of ultrasound-guided microwave ablation and traditional surgery in the treatment of plasma cell mastitis: a multicenter study[J]. Quant Imaging Med Surg, 2023, 13(3): 1838-1848. DOI: 10.21037/qims-21-1132.
34.Zhou S, Sheng C, Hu P, et al. A preliminary study of ultrasound-guided microwave ablation for nonpuerperal mastitis treatment[J]. Breast Care (Basel), 2023, 18(1): 1-11. DOI: 10.1159/000527128.
35.陈莉颖,陆德铭. 浆细胞性乳腺炎228例泌乳素水平的临床研究[J]. 实用医学杂志, 2016, 32(18): 3038-3040. [Chen LY, Lu DM. Clinical study of prolactin in 228 cases plasma cell mastitis[J]. The Journal of Practical Medicine, 2016, 32(18): 3038-3040.] DOI: 10.3969/j.issn.1006-5725.2016.18.026.
36.李涛. 乳腺导管扩张症并发感染行乳腺区域切除术结合腺体成型治疗效果及并发症分析[J]. 吉林医学, 2021, 42(8): 1952-1953. [LI T. Analysis of the effect and complications of mammary gland resection complicated with infection[J]. Jilin Medical Journal, 2021, 42(8): 1952-1953.] DOI: 10.3969/j.issn.1004-0412.2021.08.061.
Popular Papers
-
Mediating effects of social support and health literacy on self-efficacy and self-advocacy in patients with postoperative chemotherapy for breast cancer
Aug. 25, 20256524
-
Digital health interventions on chronic obstructive pulmonary disease: a scoping review
Jul. 25, 20255704
-
Analysis of depression burden and attribution risk factors among Chinese adolescents aged 10~24 from 1990 to 2021
Sep. 26, 20255181
-
Bibliometric analysis of reseach on rehabilitation training of developmental dysplasia of the hip
Jul. 25, 20255136
-
Frontier progress and future strategies in the treatment of pulmonary fibrosis
Aug. 25, 20254736
-
Relation between suicide ideation and depression, anxious symptoms, rumination and self-acceptance in adolescents with depressive disorder
Jul. 25, 20254730
-
Trends in the burden of spinal cord injury in China from 1990 to 2021
Jul. 25, 20254697
-
Analysis of the detection status and influencing factors of breast nodules in women in Zhangjiakou
Jul. 25, 20254510
-
WTAP promotes lipopolysaccharides-induced ferroptosis in human renal tubular epithelial cells by regulating ACSL4 m6A methylation
Jul. 25, 20254458
-
Difference analysis of hypertension risk factors of residents aged 40 and above in Zhongshan
Jul. 25, 20254362
-
The role of zinc homeostasis in prostate diseases and potential mechanisms
Jul. 25, 20254270
-
Analysis of cancer disease burden in China from 1990 to 2021
Aug. 25, 20254175
-
The impact of ω-3 polyunsaturated fatty acids on the recovery of autonomic nervous and intestinal functions following robot-assisted gastrectomy
Jul. 25, 20254073
-
Construction and validation of a prognostic prediction model for osteosarcoma in children based on the SEER database
Jul. 25, 20253935
-
Comparison of effects of bronchial blocker and double-lumen endobronchial tube in video-assisted thoracoscopic surgery: based on propensity score matching analysis
Jul. 25, 20253933
Welcome to visit Zhongnan Medical Journal Press Series journal website!